ANI PHARMS has announced the successful approval of its ANDA filing, enabling the company to capitalize on forecasted market opportunities in the generic sector. The green light provides a strategic boost to the company's revenue pipeline, positioning ANI PHARMS to compete head-to-head with branded market leaders.